Back to Search Start Over

The role of rapid diagnostics in managing Ebola epidemics

Authors :
Nouvellet, Pierre
Garske, Tini
Mills, Harriet L.
Nedjati-Gilani, Gemma
Hinsley, Wes
Blake, Isobel M.
Van Kerkhove, Maria D.
Cori, Anne
Dorigatti, Ilaria
Jombart, Thibaut
Riley, Steven
Fraser, Christophe
Donnelly, Christl A.
Ferguson, Neil M.
Source :
Nature. December 3, 2015, pS109, 8 p.
Publication Year :
2015

Abstract

Ebola emerged in West Africa around December 2013 and swept through Guinea, Sierra Leone and Liberia, giving rise to 27,748 confirmed, probable and suspected cases reported by 29 July 2015. Case diagnoses during the epidemic have relied on polymerase chain reaction-based tests. Owing to limited laboratory capacity and local transport infrastructure, the delays from sample collection to test results being available have often been 2 days or more. Point-of-care rapid diagnostic tests offer the potential to substantially reduce these delays. We review Ebola rapid diagnostic tests approved by the World Health Organization and those currently in development. Such rapid diagnostic tests could allow early triaging of patients, thereby reducing the potential for nosocomial transmission. In addition, despite the lower test accuracy, rapid diagnostic test-based diagnosis may be beneficial in some contexts because of the reduced time spent by uninfected individuals in health-care settings where they may be at increased risk of infection; this also frees up hospital beds. We use mathematical modelling to explore the potential benefits of diagnostic testing strategies involving rapid diagnostic tests alone and in combination with polymerase chain reaction testing. Our analysis indicates that the use of rapid diagnostic tests with sensitivity and specificity comparable with those currently under development always enhances control, whether evaluated at a health-care-unit or population level. If such tests had been available throughout the recent epidemic, we estimate, for Sierra Leone, that their use in combination with confirmatory polymerase chain-reaction testing might have reduced the scale of the epidemic by over a third. Nature 528, S109-S116 (3 December 2015), DOI: 10.1038/nature16041 This article has not been written or reviewed by Nature editors. Nature accepts no responsibility for the accuracy of the information provided.<br />The unprecedented scale of the 2014-15 West African Ebola epidemic has posed major challenges for delivering rapid diagnosis--an essential component of controlling Ebola epidemics, given the non-specific nature of early [...]

Details

Language :
English
ISSN :
00280836
Database :
Gale General OneFile
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
edsgcl.436544354
Full Text :
https://doi.org/10.1038/nature16041